COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,556 Articles (22,881 medRxiv, 8,675 bioRxiv)

Most recent first Previous |  Page 1971: Articles 19701-19710  | Next

Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay
Xue, T., Wu, W., Guo, N., Wu, C., Huang, J., Lai, L., Liu, H., Li, Y., Wang, T., Wang, Y.
10.1101/2020.12.24.424245 — Posted: 2020-12-26
Let the DOCTOR Decide Whom to Test: Adaptive Testing Strategies to Tackle the COVID-19 Pandemic
Liang, Y., Yadav, A.
10.1101/2020.12.18.20248498 — Posted: 2020-12-26
Pulmonary stromal expansion and intra-alveolar coagulation are primary causes of Covid-19 death
Szekely, L., Bozoky, B., Bendek, M., Ostad, M., Lavignasse, P., Haag, L., Wu, J., Jing, X., Gupta, S., Saccon, E., Sonnerborg, A., Cao, Y., Bjornstedt, M., Szakos, A.
10.1101/2020.12.23.424172 — Posted: 2020-12-26 Discussion: Onsite | Offsite
The SARS-CoV-2 S1 spike protein mutation N501Y alters the protein interactions with both hACE2 and human derived antibody: A Free energy of perturbation study
Fratev, F.
10.1101/2020.12.23.424283 — Posted: 2020-12-26 Discussion: Onsite | Offsite
Genomic diversity of SARS-CoV-2 can be accelerated by a mutation in the nsp14 gene
Takada, K., Ueda, M. T., Watanabe, T., Nakagawa, S.
10.1101/2020.12.23.424231 — Posted: 2020-12-26
TCR meta-clonotypes for biomarker discovery with tcrdist3: quantification of public, HLA-restricted TCR biomarkers of SARS-CoV-2 infection
Mayer-Blackwell, K., Schattgen, S., Cohen-Lavi, L., Crawford, J. C., Souquette, A., Gaevert, J. A., Hertz, T., Thomas, P. G., Bradley, P. H., Fiore-Gartland, A.
10.1101/2020.12.24.424260 — Posted: 2020-12-26
Influence of HLA class II polymorphism on predicted cellular immunity against SARS-CoV-2 at the population and individual level
Copley, H. C., Gragert, L., Leach, A. R., Kosmoliaptsis, V.
10.1101/2020.12.24.424326 — Posted: 2020-12-26
Differential Dynamic Behavior of Prefusion Spike Proteins of SARS Coronaviruses 1 and 2
Govind Kumar, V., Ogden, D. S., Isu, U., Polasa, A., Losey, J., Moradi, M.
10.1101/2020.12.25.424008 — Posted: 2020-12-26
Genetic epidemiology of variants associated with immune escape from global SARS-CoV-2 genomes
Jolly, B., Rophina, M., Shamnath, A., Imran, M., Bhoyar, R. C., Divakar, M. K., Rani, P. R., Ranjan, G., Sehgal, P., Chandrasekhar, P., Afsar, S., Lakshmi, J. V., Surekha, A., Sivasubbu, S., Scaria, V.
10.1101/2020.12.24.424332 — Posted: 2020-12-26
Support and follow-up needs of patients discharged from Intensive Care after severe COVID-19: a mixed-methods study of the views of UK general practitioners and intensive care staff during the pandemic's first wave
Castro-Avila, A. C., Jefferson, L., Dale, V., Bloor, K.
10.1101/2020.12.23.20248798 — Posted: 2020-12-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).